ML

Madan Lal Agarwal

Active Director Director DIN 08350695
DIN 08350695 First appointment Feb 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since Feb 2019
Shareholding value •••• Premium profile

About Madan Lal Agarwal

Data last updated:

Madan Lal Agarwal is a Director at Aries Drugs Private Limited (since 2024) and Director at Gemcross Formulation Private Limited (since 2026). The companies operate in Healthcare and Business Services. The largest current company by reported revenue is Aries Drugs Private Limited at ₹2.58 Cr (FY 2024). Earlier, Madan Lal Agarwal was a Director at Caresbridge Remedies Private Limited (2019–2022).

DIN 08350695
Primary Designation Director
Industry Healthcare
First Appointment 04 Feb 2019
Oldest Company Age 21 yrs
Largest company Aries Drugs Private Limited · ₹2.58 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aries Drugs Private Limited U24232UR2005PTC007478
Director02 May 20242005₹2.58 Cr (FY 2024)Active
Gemcross Formulation Private Limited U46497UT2026PTC021844
Director13 Jul 20262026Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Caresbridge Remedies Private Limited U74999UR2019PTC009469
Director04 Feb 20192019Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Madan Lal Agarwal

Directorship timeline

Open interactive timeline →
Aries Drugs Private Limited
Gemcross Formulation Private Limited
Caresbridge Remedies Private Limited
Premium access

Shareholding and investment profile for Madan Lal Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madan Lal Agarwal

Madan Lal Agarwal currently holds 2 directorships: Aries Drugs Private Limited (Director, since 02 May 2024, revenue ₹2.58 Cr (FY 2024)); Gemcross Formulation Private Limited (Director, since 13 Jul 2026).

Madan Lal Agarwal was first appointed on 04 Feb 2019 as Director at Caresbridge Remedies Private Limited. The most recent appointment on record is 13 Jul 2026 at Gemcross Formulation Private Limited.

Madan Lal Agarwal held 1 earlier board appointment: Caresbridge Remedies Private Limited (Director, 04 Feb 2019 to 01 Nov 2022).

The current boards of Madan Lal Agarwal's companies include Amit Agarwal (Aries Drugs Private Limited), Hari Om Agarwal (Aries Drugs Private Limited), Ronak Agrawal (Aries Drugs Private Limited), Chitra Agrawal (Gemcross Formulation Private Limited), Mayank Agrawal (Gemcross Formulation Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available